Company performance
Add to research
Current Price
as of Apr 25, 2025$49.53
P/E Ratio
N/A
Market Cap
$3.92B
Description
Add to research
PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in Warren, NJ.
Metrics
Add to research
Overview
- HQWarren, NJ
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerPTCT
- Price$49.53-0.04%
Trading Information
- Market cap$3.92B
- Float97.40%
- Average Daily Volume (1m)1,248,332
- Average Daily Volume (3m)961,411
- EPS-$4.73
Company
- Revenue$806.78M
- Rev growth (1yr)-13.97%
- Net income-$363.29M
- Gross margin85.36%
- EBITDA margin-8.81%
- EBITDA-$71.08M
- EV$2.72B
- EV/Revenue3.37
- P/EN/A
- P/S4.74
- P/BN/A
- Debt/EquityN/A
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account
Wikipedia